News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vanrx Pharmasystems White Paper "A New Paradigm For Manufacturing Injectable Medicines" Provides Blueprint For Flexible 21st Century Production



11/1/2016 9:34:22 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

VANCOUVER, Nov. 1, 2016 /PRNewswire/ - Vanrx Pharmasystems, a manufacturer of advanced sterile filling solutions for the pharmaceutical industry, has released a white paper titled "A New Paradigm for Manufacturing Injectable Medicines."

(Photo: http://photos.prnewswire.com/prnh/20161031/434180)

The white paper details a solution that supports the flexible production of parenteral (injectable) drug products. This solution resolves long-standing issues in aseptic production, while making manufacturers more agile to react to changing market conditions. Companies that take advantage of the improvements made possible by standardization and automation will bring their drug products to market faster and beat their competition, achieving superior market share and profitability.

The white paper provides a roadmap for manufacturing leaders to modernize their fill-finish operations by adopting the Aseptic Filling Workcell approach, consisting of robotics, automation and gloveless isolator technologies. This approach is supported by the Matrix Alliance, a collaboration between pharmaceutical packaging leaders for product compatibility and testing of nested container and closure systems.

"Every pharmaceutical company, whether they are making novel therapeutics, generics, biosimilars or contract manufacturing is being challenged to produce a more varied portfolio. The products themselves are more complex and address smaller patient populations. Early adopters of this new way of manufacturing will be the winners. They will cut months or years off their launch timelines and be able to change direction quickly via the gains in flexibility and control that are now available," said Chris Procyshyn, CEO and co-founder of Vanrx.

The white paper is available for download by visiting www.vanrx.com/whitepaper.

Vanrx will also be distributing copies of the whitepaper at its upcoming events, including PharmaExpo in Chicago from November 6-9, 2016 (Stand W-1040) and at P-MEC India in Mumbai from November 21-23, 2016 (Hall 7, S13).

About Vanrx Pharmasystems

Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit www.vanrx.com.

SOURCE Vanrx Pharmasystems Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES